Synonymous recoding of RNA virus genomes is a promising approach for generating attenuated
viruses to use as vaccines. Problematically, recoding typically hinders virus growth, but …

Background Microbiological characterisation of co-infections and secondary infections in
patients with COVID-19 is lacking, and antimicrobial use is high. We aimed to describe …

Pulmonary inflammation drives critical illness in Covid-19, 1 ; 2 creating a clinically
homogeneous extreme phenotype, which we have previously shown to be highly efficient for …

Background Prognostic models to predict the risk of clinical deterioration in acute COVID-19
cases are urgently required to inform clinical management decisions. Methods We …

Background COVID-19 is a multisystem disease and patients who survive might have in-hospital
complications. These complications are likely to have important short-term and long-…

Background Studies of patients admitted to hospital with COVID-19 have found varying
mortality outcomes associated with underlying respiratory conditions and inhaled corticosteroid …

Background Most studies of immunity to SARS-CoV-2 focus on circulating antibody, giving
limited insights into mucosal defences that prevent viral replication and onward transmission. …

An intense, nonresolving airway inflammatory response leads to destructive lung disease in
cystic fibrosis (CF). Dysregulation of macrophage immune function may be a key facet …

Background Early in the pandemic it was suggested that pre-existing use of non-steroidal
anti-inflammatory drugs (NSAIDs) could lead to increased disease severity in patients with …

Background Mortality rates in hospitalised patients with COVID-19 in the UK appeared to
decline during the first wave of the pandemic. We aimed to quantify potential drivers of this …